ArticleCancer science2025

GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab.

Tokiyoshi Tanegashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.